Antibodies | Assay Kits | Biology Cells | cDNA | Clia Kits | Culture Cells | Devices | DNA | DNA Templates | DNA Testing | Elisa Kits | Enzymes | Exosomes | Gels | Isotypes | Medium & Serums | NATtrol | Panel | Particles | PCR | Pcr Kits | Peptides | Reagents | Recombinant Proteins | Ria Kits | RNA | Test Kits | Vector & Virus | Western Blot
Sequence and organization of the human mitochondrial genome
The entire sequence of the 16,569-base pair human mitochondrial genome is introduced. The genes for the 12S and 16S rRNAs, 22 tRNAs, cytochrome c oxidase subunits I, II and III, ATPase subunit 6, cytochrome b and eight different predicted protein coding genes have been positioned.
The sequence reveals excessive financial system in that the genes have none or just a few noncoding bases between them, and in lots of circumstances the termination codons usually are not coded within the DNA however are created post-transcriptionally by polyadenylation of the mRNAs.
Epirubicin Hydrochloride | Gemcitabine Hydrochloride
- Comparability of relative fixation charges of synonymous (silent) and nonsynonymous (amino acid-altering) mutations offers a way for understanding the mechanisms of molecular sequence evolution.
- The nonsynonymous/synonymous price ratio (omega = d(N)d(S)) is a crucial indicator of selective stress on the protein stage, with omega = 1 which means impartial mutations, omega < 1 purifying choice, and omega>> 1 diversifying constructive choice.
- Amino acid websites in a protein are anticipated to be beneath completely different selective pressures and have completely different underlying omega ratios. We develop fashions that account for heterogeneous omega ratios amongst amino acid websites and apply them to phylogenetic analyses of protein-coding DNA sequences.
Ticlopidine hydrochloride | EHNA hydrochloride
- These fashions are helpful for testing for adaptive molecular evolution and figuring out amino acid websites beneath diversifying choice. Ten information sets of genes from nuclear, mitochondrial, and viral genomes are analyzed to estimate the distributions of omega amongst websites. In all information units analyzed, the selective stress indicated by the omega ratio is discovered to be extremely heterogeneous amongst websites.
- Beforehand unsuspected Darwinian choice is detected in a number of genes through which the typical omega ratio throughout websites is <1, however through which some websites are clearly beneath diversifying choice with omega>> 1. Genes present process constructive choice embody the beta-globin gene from vertebrates, mitochondrial protein-coding genes from hominoids, the hemagglutinin (HA) gene from human influenza virus A, and HIV-1 env, vif, and pol genes.
- Exams for the presence of positively chosen websites and their subsequent identification seem fairly sturdy to the particular distributional type assumed for omega and might be achieved utilizing any of a number of fashions we implement. Nonetheless, we encountered difficulties in estimating the precise distribution of omega amongst websites from actual information units.
Doxorubicin |
|||
D063-5MG | TOKU-E | 5 mg | EUR 135.26 |
Description: 23214-92-8 |
Doxorubicin |
|||
ADC-P-013 | Creative Biolabs | unit | Ask for price |
Doxorubicin |
|||
HY-15142A | MedChemExpress | 100mg | EUR 258 |
Description: Doxorubicin (Hydroxydaunorubicin), a broad-spectrum anthracycline antibiotic with cytotoxic properties, is an anti-cancer chemotherapy agent. Doxorubicin has fluorescence properties. Doxorubicin inhibits topoisomerase II with an IC50 of 2.67 μM, thus stopping DNA replication. Doxorubicin reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin induces apoptosis and autophagy[1][2]. Doxorubicin inhibits human DNA topoisomerase I with an IC50 of 0.8 μM[3]. |
Doxorubicin |
|||
MBS3840348-100mg | MyBiosource | 100mg | EUR 165 |
Doxorubicin |
|||
MBS3840348-500mg | MyBiosource | 500mg | EUR 345 |
Doxorubicin |
|||
MBS3840348-50mg | MyBiosource | 50mg | EUR 135 |
Doxorubicin |
|||
MBS3840348-5x500mg | MyBiosource | 5x500mg | EUR 1550 |
Doxorubicin |
|||
T1456-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin |
Doxorubicin [BSA] |
|||
DAG-WT1084B | Creative Diagnostics | 1 mg | EUR 520 |
Description: Synthetic |
Doxorubicin [OVA] |
|||
DAG-WT1084O | Creative Diagnostics | 1 mg | EUR 520 |
Description: Synthetic |
Doxorubicin HCl |
|||
20-abx184016 | Abbexa |
|
|
Doxorubicin HCl |
|||
abx076623-25ml | Abbexa | 25 ml | EUR 187.5 |
Doxorubicin HCl |
|||
abx076623-5ml | Abbexa | 5 ml | EUR 118.75 |
Doxorubicin 10mM |
|||
TG4120 | TopoGen | 0.25ml | EUR 187.2 |
Doxorubicin-HCl |
|||
MBS406798-1mg | MyBiosource | 1mg | EUR 1205 |
Doxorubicin-HCl |
|||
MBS406798-5x1mg | MyBiosource | 5x1mg | EUR 5385 |
Doxorubicin-SMCC |
|||
406622 | MedKoo Biosciences | 1.0mg | EUR 90 |
Doxorubicin-SMCC |
|||
HY-116063 | MedChemExpress | 10 mg | EUR 919.93 |
Description: Doxorubicin-SMCC is a agent-linker conjugate for ADC. Doxorubicin-SMCC contains a non-cleavable ADC linker and a DNA topoisomerase II inhibitor Doxorubicin[1]. |
Doxorubicin-MVCP |
|||
MBS5781169-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Doxorubicin-MVCP |
|||
T31567-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-SMCC |
|||
T15161-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-10mg | MyBiosource | 10mg | EUR 680 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-1mg | MyBiosource | 1(mg | EUR 320 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-25mg | MyBiosource | 25mg | EUR 1495 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-5mg | MyBiosource | 5mg | EUR 435 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-5x25mg | MyBiosource | 5x25mg | EUR 6570 |
Doxorubicin-13C,d3 (TFA) |
|||
HY-15142AS1 | MedChemExpress | 1mg | Ask for price |
Description: Doxorubicin-13C,d3 (TFA) is the deuterium and 13C labeled Doxorubicin. Doxorubicin (Hydroxydaunorubicin), a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin inhibits topoisomerase II with an IC50 of 2.67 μM, thus stoppin |
Zoptarelin doxorubicin |
|||
HY-16532 | MedChemExpress | Get quote | Ask for price |
Description: Zoptarelin doxorubicin (AEZS-108; AN-152) is a hybrid anticancer agent, containing Zoptarelin and Doxorubicin. Zoptarelin doxorubicin has been used to research targeting tumors expressing LHRH receptors. Zoptarelin doxorubicin abolishes tumor progression and induces remarkable apoptosis in vitro[1]. |
Adriamycin (Doxorubicin) |
|||
E1KS1208 | EnoGene | 10mg | EUR 276 |
Doxorubicin (Adriamycin) |
|||
MBS576816-100mg | MyBiosource | 100mg | EUR 150 |
Doxorubicin (Adriamycin) |
|||
MBS576816-200mg | MyBiosource | 200mg | EUR 180 |
Doxorubicin (Adriamycin) |
|||
MBS576816-25mg | MyBiosource | 25mg | EUR 135 |
Doxorubicin (Adriamycin) |
|||
MBS576816-500mg | MyBiosource | 500mg | EUR 245 |
Doxorubicin (Adriamycin) |
|||
MBS576816-50mg | MyBiosource | 50mg | EUR 145 |
Adriamycin (Doxorubicin) |
|||
MBS8579811-10mg | MyBiosource | 10mg | EUR 345 |
Adriamycin (Doxorubicin) |
|||
MBS8579811-5x10mg | MyBiosource | 5x10mg | EUR 1410 |
Doxorubicin HCl, 100mg |
|||
R2531 | ACTGene | 100mg | EUR 1080.79 |
Doxorubicin HCl, 100mg |
|||
R2531-100mg | ACTGene | each | EUR 1560 |
Doxorubicin HCl, 10mg |
|||
R2531-10mg | ACTGene | each | EUR 236.4 |
Doxorubicin Free Base |
|||
100960 | MedKoo Biosciences | 10.0mg | EUR 150 |
Doxorubicin hydrochloride |
|||
100280 | MedKoo Biosciences | 100.0mg | EUR 150 |
Doxorubicin hydrochloride |
|||
TNC00267 | ChemNorm | 20mg | Ask for price |
Doxorubicin Hydrochloride |
|||
40410004-1 | Bio-WORLD | 10 mg | EUR 175.57 |
Doxorubicin Hydrochloride |
|||
40410004-2 | Bio-WORLD | 25 mg | EUR 351.76 |
Doxorubicin Hydrochloride |
|||
D558000 | Toronto Research Chemicals | 100mg | EUR 136 |
Description: 25316-40-9 |
Doxorubicin Hydrochloride |
|||
20-abx076623 | Abbexa |
|
|
Doxorubicin hydrochloride |
|||
ADC-P-014 | Creative Biolabs | unit | Ask for price |
Doxorubicin (hydrochloride) |
|||
HY-15142 | MedChemExpress | 100mg | EUR 285.72 |
Description: Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy[1][2][3]. |
Hydroxyacetyl Doxorubicin |
|||
H415946 | Toronto Research Chemicals | 25mg | EUR 15000 |
Doxorubicin hydrochloride |
|||
GA4969-100MG | Glentham Life Sciences | 100 mg | EUR 217.2 |
Doxorubicin hydrochloride |
|||
GA4969-10MG | Glentham Life Sciences | 10 mg | EUR 93.6 |
Doxorubicin hydrochloride |
|||
GA4969-25MG | Glentham Life Sciences | 25 mg | EUR 117.6 |
Doxorubicin hydrochloride |
|||
GA4969-50MG | Glentham Life Sciences | 50 mg | EUR 151.2 |
Doxorubicin hydrochloride |
|||
MBS3603751-100mg | MyBiosource | 100mg | EUR 210 |
Doxorubicin hydrochloride |
|||
MBS3603751-200mg | MyBiosource | 200mg | EUR 245 |
Doxorubicin hydrochloride |
|||
MBS3603751-25mg | MyBiosource | 25mg | EUR 195 |
Doxorubicin hydrochloride |
|||
MBS3603751-500mg | MyBiosource | 500mg | EUR 315 |
Doxorubicin hydrochloride |
|||
MBS3603751-5x500mg | MyBiosource | 5x500mg | EUR 1075 |
Doxorubicin Hydrochloride |
|||
MBS651404-25mg | MyBiosource | 25mg | EUR 460 |
Doxorubicin Hydrochloride |
|||
MBS651404-5x25mg | MyBiosource | 5x25mg | EUR 1925 |
Doxorubicin Hydrochloride |
|||
MBS808094-10mg | MyBiosource | 10mg | EUR 250 |
Doxorubicin Hydrochloride |
|||
MBS808094-50mg | MyBiosource | 50mg | EUR 570 |
Doxorubicin Hydrochloride |
|||
MBS808094-5x10mg | MyBiosource | 5x10mg | EUR 880 |
Doxorubicin Hydrochloride |
|||
MBS808094-5x50mg | MyBiosource | 5x50mg | EUR 2300 |
Doxorubicin hydrochloride |
|||
T1020-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin hydrochloride |
Sequence and gene group of mouse mitochondrial DNA.
- The entire sequence of the 16,295 bp mouse L cell mitochondrial DNA genome has been decided. Genes for the 12S and 16S ribosomal RNAs; 22 tRNAs; cytochrome c oxidase subunits I, II and III; ATPase subunit 6; cytochrome b; and eight unidentified proteins have been positioned. The genome shows distinctive financial system of group, with tRNA genes interspersed between rRNA and protein-coding genes with zero or few noncoding nucleotides between coding sequences.
Pargyline hydrochloride | Clindamycin hydrochloride
- Solely two vital parts of the genome, the 879 nucleotide displacement-loop area containing the origin of heavy-strand duplicatetion and the 32 nucleotide origin of light-strand replication, don’t encode a useful RNA species. All the remaining nucleotide sequence serves as an outlined coding operate, excluding 32 nucleotides, of which 18 occur on the 5′ ends of open studying frames.
- Mouse mitochondrial DNA is exclusive in that the translational begin codon is AUN, with any of the 4 nucleotides within the third place, whereas the one translational cease codon is the orthodox UAA. The mouse mitochondrial DNA genome is extremely homologous in total sequence and in gene group to human mitochondrial DNA, with the descending order of conserved areas being tRNA genes; origin of light-strand replication; rRNA genes; identified protein-coding genes; unidentified protein-coding genes; displacement-loop area.
- Mitochondrial DNA was purified from 4 species of upper primates (Guinea baboon, rhesus macaque, guenon, and human) and digested with 11 restriction endonucleases. A cleavage map was constructed for the mitochondrial DNA of every species. Comparability of the maps, aligned with respect to the origin and course of DNA replication, revealed that the species differ from each other at many of the cleavage websites. The diploma of divergence in nucleotide sequence at these websites was calculated from the fraction of cleavage websites shared by every pair of species.
Enzalutamide |
|||
T6002-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Enzalutamide |
Enzalutamide |
|||
T6002-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Enzalutamide |
Enzalutamide-d6 |
|||
HY-70002S1 | MedChemExpress | 1 mg | EUR 811.7 |
Description: Enzalutamide-d6 is a deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells[1]. |
Enzalutamide-d3 |
|||
T11208-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Enzalutamide-d3 |
Enzalutamide-d3 |
|||
T11208-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Enzalutamide-d3 |
Enzalutamide-d3 |
|||
T11208-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Enzalutamide-d3 |
Enzalutamide-d3 |
|||
T11208-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Enzalutamide-d3 |
Enzalutamide-d3 |
|||
T11208-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Enzalutamide-d3 |
MDV 3100 (Enzalutamide) |
|||
M199800 | Toronto Research Chemicals | 100mg | EUR 144 |
Description: 915087-33-1 |
MDV3100 (Enzalutamide) |
|||
A3003-10 | ApexBio | 10 mg | EUR 40 |
Description: Endocrinology and Hormones|Androgen Receptor |
MDV3100 (Enzalutamide) |
|||
A3003-25 | ApexBio | 25 mg | EUR 182.4 |
Description: Endocrinology and Hormones|Androgen Receptor |
MDV3100 (Enzalutamide) |
|||
A3003-5 | ApexBio | 5 mg | EUR 72 |
Description: Endocrinology and Hormones|Androgen Receptor |
MDV3100 (Enzalutamide) |
|||
A3003-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 68 |
Description: Endocrinology and Hormones|Androgen Receptor |
MDV3100 (Enzalutamide) |
|||
A3003-50 | ApexBio | 50 mg | EUR 104 |
Description: Endocrinology and Hormones|Androgen Receptor |
MDV3100 (Enzalutamide) |
|||
A3003-S | ApexBio | Evaluation Sample | EUR 24 |
Description: Endocrinology and Hormones|Androgen Receptor |
Enzalutamide (MDV3100) |
|||
201821 | MedKoo Biosciences | 50.0mg | EUR 90 |
MDV3100 Enzalutamide |
|||
MBS132079-100mg | MyBiosource | 100mg | EUR 1065 |
MDV3100 Enzalutamide |
|||
MBS132079-500mg | MyBiosource | 500mg | EUR 2775 |
Enzalutamide (MDV3100) |
|||
MBS578579-10mg | MyBiosource | 10mg | EUR 150 |
Enzalutamide (MDV3100) |
|||
MBS578579-25mg | MyBiosource | 25mg | EUR 155 |
Enzalutamide (MDV3100) |
|||
MBS578579-2mg | MyBiosource | 2mg | EUR 120 |
Enzalutamide (MDV3100) |
|||
MBS578579-50mg | MyBiosource | 50mg | EUR 180 |
Enzalutamide (MDV3100) |
|||
MBS578579-5mg | MyBiosource | 5mg | EUR 145 |
N-desmethyl Enzalutamide |
|||
HY-70002A | MedChemExpress | 100mg | EUR 606.07 |
Description: N-desmethyl Enzalutamide is the active metabolite of Enzalutamide.N-desmethyl Enzalutamide is the active metabolite of Enzalutamide. N-desmethyl Enzalutamide demonstrates primary and secondary pharmacodynamics of similar potency to Enzalutamide and circulates at approximately the same plasma concentrations as enzalutamide[1]. |
N-desmethyl Enzalutamide |
|||
MBS3600977-10mg | MyBiosource | 10mg | EUR 260 |
N-desmethyl Enzalutamide |
|||
MBS3600977-50mg | MyBiosource | 50mg | EUR 575 |
N-desmethyl Enzalutamide |
|||
MBS3600977-5x50mg | MyBiosource | 5x50mg | EUR 2260 |
N-desMethyl EnzalutaMide |
|||
MBS3840124-10mg | MyBiosource | 10mg | EUR 220 |
N-desMethyl EnzalutaMide |
|||
MBS3840124-25mg | MyBiosource | 25mg | EUR 360 |
N-desMethyl EnzalutaMide |
|||
MBS3840124-50mg | MyBiosource | 50mg | EUR 580 |
N-desMethyl EnzalutaMide |
|||
MBS3840124-5x50mg | MyBiosource | 5x50mg | EUR 2600 |
N-desmethyl Enzalutamide |
|||
MBS5756064-100mg | MyBiosource | 100mg | EUR 775 |
N-desmethyl Enzalutamide |
|||
MBS5756064-10mg | MyBiosource | 10mg | EUR 190 |
N-desmethyl Enzalutamide |
|||
MBS5756064-2mg | MyBiosource | 2mg | EUR 150 |
N-desmethyl Enzalutamide |
|||
MBS5756064-50mg | MyBiosource | 50mg | EUR 465 |
N-desmethyl Enzalutamide |
|||
MBS5756064-5mg | MyBiosource | 5mg | EUR 170 |
N-desmethyl Enzalutamide |
|||
T19450-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: N-desmethyl Enzalutamide |
N-desmethyl Enzalutamide |
|||
T19450-1g | TargetMol Chemicals | 1g | Ask for price |
Description: N-desmethyl Enzalutamide |
N-desmethyl Enzalutamide |
|||
T19450-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: N-desmethyl Enzalutamide |
N-desmethyl Enzalutamide |
|||
T19450-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: N-desmethyl Enzalutamide |
N-desmethyl Enzalutamide |
|||
T19450-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: N-desmethyl Enzalutamide |
Enzalutamide carboxylic acid |
|||
HY-70002B | MedChemExpress | 1 mg | EUR 606.07 |
Description: Enzalutamide carboxylic acid (MDV3100 carboxylic acid) is an inactive metabolite of Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist[1]. |
Enzalutamide Carboxylic Acid |
|||
E559800 | Toronto Research Chemicals | 2.5mg | EUR 2067 |
Description: 1242137-15-0 |
Enzalutamide carboxylic acid |
|||
MBS3611549-10mg | MyBiosource | 10mg | EUR 375 |
Enzalutamide carboxylic acid |
|||
MBS3611549-25mg | MyBiosource | 25mg | EUR 475 |
Enzalutamide carboxylic acid |
|||
MBS3611549-2mg | MyBiosource | 2mg | EUR 245 |
Enzalutamide carboxylic acid |
|||
MBS3611549-50mg | MyBiosource | 50mg | EUR 650 |
Enzalutamide carboxylic acid |
|||
MBS3611549-5mg | MyBiosource | 5mg | EUR 315 |
Enzalutamide carboxylic acid |
|||
MBS5759031-10mg | MyBiosource | 10mg | EUR 275 |
Enzalutamide carboxylic acid |
|||
MBS5759031-1mg | MyBiosource | 1mg | EUR 150 |
Enzalutamide carboxylic acid |
|||
MBS5759031-25mg | MyBiosource | 25mg | EUR 390 |
Enzalutamide carboxylic acid |
|||
MBS5759031-2mg | MyBiosource | 2mg | EUR 175 |
Enzalutamide carboxylic acid |
|||
MBS5759031-5mg | MyBiosource | 5mg | EUR 215 |
Enzalutamide carboxylic acid |
|||
T8217-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Enzalutamide carboxylic acid |
Enzalutamide carboxylic acid |
|||
T8217-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Enzalutamide carboxylic acid |
Enzalutamide carboxylic acid |
|||
T8217-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Enzalutamide carboxylic acid |
Enzalutamide carboxylic acid |
|||
T8217-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Enzalutamide carboxylic acid |
Enzalutamide carboxylic acid |
|||
T8217-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Enzalutamide carboxylic acid |
N-desmethyl Enzalutamide D6 |
|||
T19449-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: N-desmethyl Enzalutamide D6 |
N-desmethyl Enzalutamide D6 |
|||
T19449-1g | TargetMol Chemicals | 1g | Ask for price |
Description: N-desmethyl Enzalutamide D6 |
N-desmethyl Enzalutamide D6 |
|||
T19449-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: N-desmethyl Enzalutamide D6 |
N-desmethyl Enzalutamide D6 |
|||
T19449-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: N-desmethyl Enzalutamide D6 |
N-desmethyl Enzalutamide D6 |
|||
T19449-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: N-desmethyl Enzalutamide D6 |
MDV 3100-d6 (Enzalutamide-d6) |
|||
M199803 | Toronto Research Chemicals | 10mg | EUR 184 |
Description: 1443331-94-9 |
N-desmethyl Enzalutamide-d6 |
|||
HY-70002AS | MedChemExpress | 1 mg | EUR 811.7 |
Description: N-desmethyl Enzalutamide-d6 is a deuterium labeled N-desmethyl Enzalutamide. N-desmethyl Enzalutamide is an active metabolite of Enzalutamide. N-desmethyl Enzalutamide is the active metabolite of Enzalutamide. N-desmethyl Enzalutamide demonstrates primary and secondary pharmacodynamics of similar potency to Enzalutamide and circulates at approximately the same plasma concentrations as enzalutamide[1]. |
Enzalutamide carboxylic acid D6 |
|||
T19311-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Enzalutamide carboxylic acid D6 |
Enzalutamide carboxylic acid D6 |
|||
T19311-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Enzalutamide carboxylic acid D6 |
Enzalutamide carboxylic acid D6 |
|||
T19311-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Enzalutamide carboxylic acid D6 |
Enzalutamide carboxylic acid D6 |
|||
T19311-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Enzalutamide carboxylic acid D6 |
Enzalutamide carboxylic acid D6 |
|||
T19311-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Enzalutamide carboxylic acid D6 |
Enzalutamide carboxylic acid-d6 |
|||
HY-70002BS | MedChemExpress | 5 mg | EUR 1011.92 |
Description: Enzalutamide carboxylic acid-d6 is the deuterium labeled Enzalutamide carboxylic acid (MDV3100 carboxylic acid). Enzalutamide carboxylic acid is an inactive metabolite of Enzalutamide[1]. |
Enzalutamide Related Compound-D |
|||
E531130 | Toronto Research Chemicals | 500mg | EUR 4500 |
Enzalutamide Related Compound-C |
|||
E531140 | Toronto Research Chemicals | 250mg | EUR 7600 |
Demethylamine tert-Butoxy Enzalutamide |
|||
D230813 | Toronto Research Chemicals | 100mg | EUR 3000 |
Enzalutamide N-2'-(Trifluoromethyl)benzonitrile |
|||
E559805 | Toronto Research Chemicals | 100mg | EUR 4500 |
N-(1-(Amino)-2-methyl-1-oxopropan-2-yl)formamido Enzalutamide |
|||
A199800 | Toronto Research Chemicals | 50mg | EUR 1200 |
Defluoro-MDV 3100 (Defluoro-enzalutamide) |
|||
D228590 | Toronto Research Chemicals | 10mg | EUR 221 |
Description: 915087-16-0 |
Oxo-MDV 3100 (Oxo-enzalutamide) |
|||
O857800 | Toronto Research Chemicals | 100mg | EUR 178 |
Description: 1242137-18-3 |
N-desmethyl MDV3100, N-desmethyl-Enzalutamide |
|||
MBS130369-100mg | MyBiosource | 100mg | EUR 1065 |
N-desmethyl MDV3100, N-desmethyl-Enzalutamide |
|||
MBS130369-500mg | MyBiosource | 500mg | EUR 2775 |
- By plotting the diploma of divergence in mitochondrial DNA in opposition to time of divergence, the speed of base substitution could possibly be calculated from the initial slope of the curve. The worth obtained, 0.02 substitutions per base pair per million years, was in contrast with the worth for single-copy nuclear DNA.
Asenapine hydrochloride | AT7519 Hydrochloride
- The speed of evolution of the mitochondrial genome seems to exceed that of the single-copy fraction of the nuclear genome by an element of about 10. This excessive price might be due, partially, to an elevated price of mutation in mitochondrial DNA. Due to the excessive price of evolution, mitochondrial DNA is prone to be a particularly helpful molecule to make use of for high-resolution evaluation of the evolutionary course of.
Source : beylikdüzü escort
No Comment